GlassScriptPrepare for your visit
Hollin E Calloway
Otolaryngology/Facial Plastic Surgery · Hoboken, NJ · NPI 1528325453
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,260.67
in general payments reported to CMS, 2019-2025 · $495 in 2025
The $495 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Who reported paying
General payments only, top 6 by amount.
- Genzyme Corporation $352.74
- Glaxosmithkline, LLC. $299.79
- Optinose US, INC. $185.14
- Alk-Abello, INC $53.67
- Regeneron Healthcare Solutions, INC. $47.96
- Stryker Corporation $46.53
Drugs and devices associated with these payments
Dupixent Nucala Xhance Neffy Scopis Ent Rhinaer Stylus Vivaer Stylus Inspire Tezspire Propel Auvi-Q Rhapsido
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Hollin Calloway listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/2817042/hollin-e-calloway